Wolfgang Flasche Image

Wolfgang Flasche

Dr. rer. nat. Dipl. Chem

Bardehle Pagenberg

Wolfgang Flasche’s practice with Bardehle Pagenberg  involves patent prosecution and litigation in the fields of biotechnology, biology, medicine, and chemistry. His background is based on many years of experience gained while leading the patent group at Immatics Biotechnologies in Munich, Tübingen, and Houston (Texas).

He has considerable expertise in developing IP strategies that focus on risk management on the one hand and expansion and scaling opportunities for patent applicants and innovators on the other. In this area, he has built and developed the portfolio of Immatics Biotechnologies in various technology areas over more than 16 years.

In recent years, Wolfgang Flasche has been able to contribute to several licensing and partnership agreements with large pharmaceutical companies worth hundreds of millions of euros.

His commercial focus contributed to successful due diligences and the equally successful IPO of Immatics NV at NASDAQ.

Wolfgang Flasche also focuses on extensive FTO research and analyses.

He is an expert in building long-term strategies to protect a company’s underlying technology. He has also been able to win several complex patentability (35 U.S. Code §101) cases at the PTAB (see, e.g., Immatics biotechnologies GmbH, 14531472 – (D) (P.T.A.B. Sep. 21, 2020) and Immatics biotechnologies GmbH, 15226098 – (D) (P.T.A.B. Oct. 27, 2020)). Wolfgang has authored 6 scientific papers, two papers on intellectual property and is the co-inventor of a patent application based on his PhD thesis.

Recent Articles by Wolfgang Flasche

Recent Boards of Appeal Decisions on Added Matter: Holding up the Standard

The European Patent Office’s (EPO) Boards of Appeal have displayed a stringent approach towards added subject matter in recent decisions, particularly in comparison to other jurisdictions. This stringency is rooted in the provisions of Article 123(2) of the European Patent Convention (EPC), which prohibits amendments that extend beyond the content of the original patent application. The primary objective is to maintain the correlation between the granted patent’s scope of protection and the technical disclosure initially provided in the application.